sameAs
From bench to bedside: immunotherapy for prostate cancerMapping, genomic organization and promoter analysis of the human prostate-specific membrane antigen gene3D Cultures of prostate cancer cells cultured in a novel high-throughput culture platform are more resistant to chemotherapeutics compared to cells cultured in monolayerZoledronic acid preserves bone structure and increases survival but does not limit tumour incidence in a prostate cancer bone metastasis modelLarge-scale delineation of secreted protein biomarkers overexpressed in cancer tissue and serumGenome-wide synteny through highly sensitive sequence alignment: Satsuma.Exosomes in prostate cancer: putting together the pieces of a puzzle.Tryptic digestion of in-gel proteins for mass spectrometry analysis.Purine Nucleoside Phosphorylase mediated molecular chemotherapy and conventional chemotherapy: a tangible union against chemoresistant cancerIL-18 inhibits growth of murine orthotopic prostate carcinomas via both adaptive and innate immune mechanismsMutations within the tumour suppressor gene p53 are not confined to a late event in prostate cancer progression. a review of the evidence.Macrophage inhibitory cytokine-1 (MIC-1/GDF15) slows cancer development but increases metastases in TRAMP prostate cancer prone mice.Animal models of prostate cancer.Establishing prostate cancer patient derived xenografts: lessons learned from older studiesMacrophage inhibitory cytokine-1 (MIC-1/GDF15) gene deletion promotes cancer growth in TRAMP prostate cancer prone micePlant-derived MINA-05 inhibits human prostate cancer proliferation in vitro and lymph node spread in vivoKAI1 tetraspanin and metastasis suppressor.Oncogenic action of phospholipase A2 in prostate cancer.Label-free isolation of a prostate cancer cell among blood cells and the single-cell measurement of drug accumulation using an integrated microfluidic chip.Novel gene-directed enzyme prodrug therapies against prostate cancer.Tie-2 regulates the stemness and metastatic properties of prostate cancer cells.Cytosolic phospholipase A2-alpha: a potential therapeutic target for prostate cancerRole of the Akt pathway in prostate cancer.Innovative biomarkers for prostate cancer early diagnosis and progression.Promising tumor-associated antigens for future prostate cancer therapy.Molecular and traditional chemotherapy: a united front against prostate cancer.Modeling prostate cancer: a perspective on transgenic mouse models.Emerging roles for phospholipase A2 enzymes in cancer.Concise review: Nanoparticles and cellular carriers-allies in cancer imaging and cellular gene therapy?Clinical pharmacology of isoflavones and its relevance for potential prevention of prostate cancer.Humanised xenograft models of bone metastasis revisited: novel insights into species-specific mechanisms of cancer cell osteotropism.Urokinase-type plasminogen activator and its receptor in colorectal cancer: independent prognostic factors of metastasis and cancer-specific survival and potential therapeutic targets.Relationship between expression of KAI1 metastasis suppressor gene, mRNA levels and p53 in human bladder and prostate cancer cell lines.Evaluation of Polymeric Nanomedicines Targeted to PSMA: Effect of Ligand on Targeting Efficiency.PSMA-targeting iron oxide magnetic nanoparticles enhance MRI of preclinical prostate cancer.A novel model of bone-metastatic prostate cancer in immunocompetent mice.Molecular chemotherapy and chemotherapy: a new front against late-stage hormone-refractory prostate cancer.Engineered silk fibroin protein 3D matrices for in vitro tumor model.An inverse relationship between KAI1 expression, invasive ability, and MMP-2 expression and activity in bladder cancer cell lines.Multifunctional core-shell magnetic cisplatin nanocarriers.
P50
Q26864390-70AC829A-D09C-4D19-B5A8-77992D774543Q28290465-1A634253-AFAD-4863-8ED5-E7176604A4A1Q28544801-E2440BB5-8701-49BA-974A-2E0543298B94Q28744548-1C940311-6C8D-4AE7-B903-A42670670B43Q30452357-47EB1DB3-8B98-45B9-9C18-D374DB9F7C17Q30475612-7749D0B7-B697-4B96-88B8-7539CFE94C02Q33357387-B49B540A-01B4-478D-B26D-ED270828AAF2Q33432918-64F065B3-0A7D-4787-8169-2E6FC02C4EBDQ34001266-F46308EA-B7A3-4CB8-AEDF-CECC5DB7C712Q34026026-EE6E5140-7010-4FCA-92DD-867FC8D58C43Q34245527-7F0C2E13-5AD5-49DB-8288-A780CFCB594DQ34405669-6F163255-BA2A-4F99-8945-E46BF8EEEB83Q35118892-117A707B-589B-4809-A618-8ADE31621BA6Q35556598-E3EABCC1-BB52-46AA-9A77-69F4951164AAQ35563909-ABF996CC-CDE2-4B85-B6EC-08777D9E8978Q35756991-0778BD0A-C2FB-469C-AAC2-2DD3C2C1A527Q35993086-8AFCA47C-7F50-4804-919A-7D4E9BCE323BQ36267076-D7943749-A380-43CB-BE50-333A33847F34Q36277902-05E52279-1763-4A7D-A602-1EA182AB4ECFQ36543076-D467A5CB-41E1-48BE-9A87-C8B88FF86127Q36771868-E76DDE2D-D06D-4BD6-ADAB-407359531429Q37020802-DD0D6926-9862-4174-9895-28971E286224Q37411700-5A935A7C-2DC2-4E75-B558-03F361ECC649Q37425887-0CC51B93-566E-4BE3-9FB3-C460A70A2034Q37523602-E2EDB82E-71C9-41B9-8547-23E6ECD8AA88Q37684492-C44B6E17-E205-4488-B51C-AD9D12B5ED92Q37689550-89E91D5F-A9D0-474B-896C-0B49E79DAFFDQ37723476-CFCE9CCF-791F-4B5D-975A-C29FEC6D42F7Q37772453-EF7CE2F6-BE70-4A99-ACD6-CBAED2A17C22Q37783352-9D40604B-53C4-4293-8FFD-A88E7B7C5561Q38105265-C11EE7A6-1B2A-4825-87FD-2BF22EF00E03Q38308022-EC5CD8E2-A371-4F11-8340-90FC09F5DEF7Q38359952-EAC48DF9-8C0D-4011-BEAA-CD2DE1CD4BF6Q38838352-4D4F028A-D21B-40FC-A1C6-E497664C7F33Q38939408-28AB935D-3F88-4164-AC39-FC269D313301Q39366115-24B80DBC-2CBD-4557-997A-3DC1FF4F3E07Q39550577-4CB8E6FB-9633-419A-AB4F-24275D1757B2Q39618685-ED5F2F0D-649B-4F1D-BD32-BEA35E443076Q39652187-D3D786C2-25B9-4091-BF25-199A35648AC7Q39760991-512BB42A-9896-4221-BEE6-FDC8B2D8459B
P50
description
Australian immunologist
@en
aŭstralia imunologo
@eo
immunoloog
@nl
imunolojiste australian
@lfn
հետազոտող
@hy
name
Pamela J. Russell
@nl
Pamela J. Russell
@sl
Pamela Russell
@ast
Pamela Russell
@de
Pamela Russell
@en
Pamela Russell
@es
Pamela Russell
@it
باميلا راسيل
@ar
type
label
Pamela J. Russell
@nl
Pamela J. Russell
@sl
Pamela Russell
@ast
Pamela Russell
@de
Pamela Russell
@en
Pamela Russell
@es
Pamela Russell
@it
باميلا راسيل
@ar
altLabel
Pamela J. Russell
@ast
Pamela J. Russell
@en
Pamela Joan Russell
@en
باميلا جيه. راسيل
@ar
prefLabel
Pamela J. Russell
@nl
Pamela J. Russell
@sl
Pamela Russell
@ast
Pamela Russell
@de
Pamela Russell
@en
Pamela Russell
@es
Pamela Russell
@it
باميلا راسيل
@ar
P108
P1053
G-1685-2010
P1153
35474507800
P21
P31
P3829
P496
0000-0002-3995-1239